Need to Calibrate Low‑Cost Air Quality Sensors for Local Conditions, Study Warns

IMT News Desk
IMT News Desk
· 2 min read
CSTEP study finds that low‑cost air quality sensors must be calibrated for local conditions to deliver reliable pollution data

A new evaluation of low‑cost air quality sensors used in Indian cities has found that their pollutant readings can differ widely between manufacturers and even between devices from the same brand, underscoring the need to calibrate each sensor for local weather and pollution patterns before deployment. The study, “Performance Evaluation of Multi‑pollutant Air Quality Sensors at Indi‑SET, Bengaluru, India, First Edition; A Short‑ and Medium‑Term Evaluation,” was carried out by the Bengaluru‑based think tank Centre for Study of Science, Technology and Policy (CSTEP) and released this week.

The analysis examined 48 multi‑pollutant sensor units from six different manufacturers commonly deployed in India, placing them next to a reference‑grade air‑quality monitor and observing them for up to eight months. The devices measured key pollutants including PM2.5, PM10, nitrogen dioxide, ozone and carbon monoxide, and the study found that manufacturer‑provided calibration data often produced readings that varied substantially from the reference instrument, especially over time. Some sensors either stopped working entirely or began delivering clearly inaccurate values, raising concerns about long‑term reliability in public‑health and policy‑making applications.

Researchers linked the discrepancies to the fact that manufacturers often calibrate sensors under different environmental conditions and pollutant mixtures than those found in Indian cities such as Bengaluru. When the team recalibrated the devices using local conditions specific to Bengaluru, performance improved markedly, reinforcing the importance of city‑ or region‑specific calibration models. The study therefore recommends that low‑cost sensors always be calibrated before rollout and that their accuracy be rechecked every three to six months, as sensor drift and changing environmental conditions can render earlier calibration settings obsolete.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk